Malignant rhabdoid tumor of the vulva. Case report

M. Bilal Sert, M. Onsrud, T. Perrone, Fouad Abbas, J. L. Currie

Research output: Contribution to journalArticle

Abstract

The poor prognosis of malignant rhabdoid tumor is emphasized and histopathological criteria for distinction from epithelial sarcoma of the vulva are discussed. Immunohistochemical analyses were performed by using nine different antigens including vimentin, cytokeratin, epithelial membrane antigen, carcinoembryonic antigen, desmin, muscle-specific actin, S-100 protein, AP-15, neuron specific enolase. This is the sixth reported case of a malignant rhabdoid tumor of the vulva. The patient died eight months after the initial diagnosis in spite of a combination of surgery, adjuvant chemotherapy and external radiotherapy.

Original languageEnglish (US)
Pages (from-to)258-261
Number of pages4
JournalEuropean Journal of Gynaecological Oncology
Volume20
Issue number4
StatePublished - 1999

Fingerprint

Rhabdoid Tumor
Vulva
Mucin-1
Desmin
S100 Proteins
Phosphopyruvate Hydratase
Carcinoembryonic Antigen
Vimentin
Adjuvant Chemotherapy
Keratins
Sarcoma
Actins
Radiotherapy
Antigens
Muscles

Keywords

  • Malignant rhabdoid tumor
  • Treatment
  • Vulva

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology

Cite this

Sert, M. B., Onsrud, M., Perrone, T., Abbas, F., & Currie, J. L. (1999). Malignant rhabdoid tumor of the vulva. Case report. European Journal of Gynaecological Oncology, 20(4), 258-261.

Malignant rhabdoid tumor of the vulva. Case report. / Sert, M. Bilal; Onsrud, M.; Perrone, T.; Abbas, Fouad; Currie, J. L.

In: European Journal of Gynaecological Oncology, Vol. 20, No. 4, 1999, p. 258-261.

Research output: Contribution to journalArticle

Sert, MB, Onsrud, M, Perrone, T, Abbas, F & Currie, JL 1999, 'Malignant rhabdoid tumor of the vulva. Case report', European Journal of Gynaecological Oncology, vol. 20, no. 4, pp. 258-261.
Sert MB, Onsrud M, Perrone T, Abbas F, Currie JL. Malignant rhabdoid tumor of the vulva. Case report. European Journal of Gynaecological Oncology. 1999;20(4):258-261.
Sert, M. Bilal ; Onsrud, M. ; Perrone, T. ; Abbas, Fouad ; Currie, J. L. / Malignant rhabdoid tumor of the vulva. Case report. In: European Journal of Gynaecological Oncology. 1999 ; Vol. 20, No. 4. pp. 258-261.
@article{6cb6ca191185487e8b3f7c8b4e375f30,
title = "Malignant rhabdoid tumor of the vulva. Case report",
abstract = "The poor prognosis of malignant rhabdoid tumor is emphasized and histopathological criteria for distinction from epithelial sarcoma of the vulva are discussed. Immunohistochemical analyses were performed by using nine different antigens including vimentin, cytokeratin, epithelial membrane antigen, carcinoembryonic antigen, desmin, muscle-specific actin, S-100 protein, AP-15, neuron specific enolase. This is the sixth reported case of a malignant rhabdoid tumor of the vulva. The patient died eight months after the initial diagnosis in spite of a combination of surgery, adjuvant chemotherapy and external radiotherapy.",
keywords = "Malignant rhabdoid tumor, Treatment, Vulva",
author = "Sert, {M. Bilal} and M. Onsrud and T. Perrone and Fouad Abbas and Currie, {J. L.}",
year = "1999",
language = "English (US)",
volume = "20",
pages = "258--261",
journal = "European Journal of Gynaecological Oncology",
issn = "0392-2936",
publisher = "S.O.G. CANADA Inc.",
number = "4",

}

TY - JOUR

T1 - Malignant rhabdoid tumor of the vulva. Case report

AU - Sert, M. Bilal

AU - Onsrud, M.

AU - Perrone, T.

AU - Abbas, Fouad

AU - Currie, J. L.

PY - 1999

Y1 - 1999

N2 - The poor prognosis of malignant rhabdoid tumor is emphasized and histopathological criteria for distinction from epithelial sarcoma of the vulva are discussed. Immunohistochemical analyses were performed by using nine different antigens including vimentin, cytokeratin, epithelial membrane antigen, carcinoembryonic antigen, desmin, muscle-specific actin, S-100 protein, AP-15, neuron specific enolase. This is the sixth reported case of a malignant rhabdoid tumor of the vulva. The patient died eight months after the initial diagnosis in spite of a combination of surgery, adjuvant chemotherapy and external radiotherapy.

AB - The poor prognosis of malignant rhabdoid tumor is emphasized and histopathological criteria for distinction from epithelial sarcoma of the vulva are discussed. Immunohistochemical analyses were performed by using nine different antigens including vimentin, cytokeratin, epithelial membrane antigen, carcinoembryonic antigen, desmin, muscle-specific actin, S-100 protein, AP-15, neuron specific enolase. This is the sixth reported case of a malignant rhabdoid tumor of the vulva. The patient died eight months after the initial diagnosis in spite of a combination of surgery, adjuvant chemotherapy and external radiotherapy.

KW - Malignant rhabdoid tumor

KW - Treatment

KW - Vulva

UR - http://www.scopus.com/inward/record.url?scp=0033492050&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033492050&partnerID=8YFLogxK

M3 - Article

C2 - 10475117

AN - SCOPUS:0033492050

VL - 20

SP - 258

EP - 261

JO - European Journal of Gynaecological Oncology

JF - European Journal of Gynaecological Oncology

SN - 0392-2936

IS - 4

ER -